The combination of open-source software with artificial intelligence is opening up new possibilities for custom software ...

Did you know that over 90% of startups fail, and one of the biggest reasons is how long it takes to actually ship a product?

Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop small-molecule drugs through AI to treat obesity and other cardiometabolic diseases.